Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Neoplasms × Methods × Clear all

Phase

Phase NA 30 Phase EARLY_PHASE1 2 Phase 3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Lymphoma 2 Hematologic Neoplasms 2 Head and Neck Neoplasms 2 Rectal Neoplasms 1 Pain 1 Neoplasms 1 Mucositis 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphedema 1 Glioma 1 Fallopian Tube Neoplasms 1 Carcinoma in Situ 1 Brenner Tumor 1 Breast Neoplasms 1 Anatomic Stage I Breast Cancer AJCC v8 1 Abnormalities, Radiation-Induced 1

Interventions

Paclitaxel 19 Dexamethasone 16 Bevacizumab 16 Oxaliplatin 14 Docetaxel 14 Cyclophosphamide 12 Capecitabine 12 Gemcitabine 11 Sorafenib 10 Leucovorin 10 Fluorouracil 10 Carboplatin 10 Epoetin Alfa 9 pembrolizumab 8 Pemetrexed 8 Fentanyl 8 venetoclax 7 atezolizumab 7 Rivaroxaban 7 Prednisone 7 Drug Therapy 7 Doxorubicin 7 Anastrozole 7 Rituximab 6 Ondansetron 6 Morphine 6 Irinotecan 6 Denosumab 6 Cisplatin 6 Tranexamic Acid 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01272024 2016-06-15

TEAMS

Yale University

Phase 3 Completed

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡